Leeds JM - Search Results

1

Inhibition of human immunodeficiency virus type 1 infection in SCID-hu Thy/Liv mice by the G-quartet-forming oligonucleotide, ISIS 5320.

Stoddart CA, Rabin L, Hincenbergs M, Moreno M, Linquist-Stepps V, Leeds JM, Truong LA, Wyatt JR, Ecker DJ, McCune JM. Stoddart CA, et al. Among authors: leeds jm. Antimicrob Agents Chemother. 1998 Aug;42(8):2113-5. doi: 10.1128/AAC.42.8.2113. Antimicrob Agents Chemother. 1998. PMID: 9687417 Free PMC article.

2

Quantitation of phosphorothioate oligonucleotides in human plasma.

Leeds JM, Graham MJ, Truong L, Cummins LL. Leeds JM, et al. Anal Biochem. 1996 Mar 1;235(1):36-43. doi: 10.1006/abio.1996.0088. Anal Biochem. 1996. PMID: 8850544

3

Pharmacokinetics of a potential human cytomegalovirus therapeutic, a phosphorothioate oligonucleotide, after intravitreal injection in the rabbit.

Leeds JM, Henry SP, Truong L, Zutshi A, Levin AA, Kornbrust D. Leeds JM, et al. Drug Metab Dispos. 1997 Aug;25(8):921-6. Drug Metab Dispos. 1997. PMID: 9280399

4

Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression.

Geary RS, Leeds JM, Fitchett J, Burckin T, Truong L, Spainhour C, Creek M, Levin AA. Geary RS, et al. Among authors: leeds jm. Drug Metab Dispos. 1997 Nov;25(11):1272-81. Drug Metab Dispos. 1997. PMID: 9351904

5

Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action.

Henry SP, Giclas PC, Leeds J, Pangburn M, Auletta C, Levin AA, Kornbrust DJ. Henry SP, et al. J Pharmacol Exp Ther. 1997 May;281(2):810-6. J Pharmacol Exp Ther. 1997. PMID: 9152389

6

Preclinical evaluation of the effects of a novel antisense compound targeting C-raf kinase in mice and monkeys.

Monteith DK, Geary RS, Leeds JM, Johnston J, Monia BP, Levin AA. Monteith DK, et al. Among authors: leeds jm. Toxicol Sci. 1998 Dec;46(2):365-75. doi: 10.1006/toxs.1998.2527. Toxicol Sci. 1998. PMID: 10048140

7

Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase.

Byrd CM, Grosenbach DW, Berhanu A, Dai D, Jones KF, Cardwell KB, Schneider C, Yang G, Tyavanagimatt S, Harver C, Wineinger KA, Page J, Stavale E, Stone MA, Fuller KP, Lovejoy C, Leeds JM, Hruby DE, Jordan R. Byrd CM, et al. Among authors: leeds jm. Antimicrob Agents Chemother. 2013 Apr;57(4):1902-12. doi: 10.1128/AAC.02251-12. Epub 2013 Feb 12. Antimicrob Agents Chemother. 2013. PMID: 23403421 Free PMC article.

8

Inhibition of coagulation by a phosphorothioate oligonucleotide.

Henry SP, Novotny W, Leeds J, Auletta C, Kornbrust DJ. Henry SP, et al. Antisense Nucleic Acid Drug Dev. 1997 Oct;7(5):503-10. doi: 10.1089/oli.1.1997.7.503. Antisense Nucleic Acid Drug Dev. 1997. PMID: 9361909

9

Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302).

Glover JM, Leeds JM, Mant TG, Amin D, Kisner DL, Zuckerman JE, Geary RS, Levin AA, Shanahan WR Jr. Glover JM, et al. Among authors: leeds jm. J Pharmacol Exp Ther. 1997 Sep;282(3):1173-80. J Pharmacol Exp Ther. 1997. PMID: 9316823 Clinical Trial.

10

Nuclease resistance of oligonucleotides containing the tricyclic cytosine analogues phenoxazine and 9-(2-aminoethoxy)-phenoxazine ("G-clamp") and origins of their nuclease resistance properties.

Maier MA, Leeds JM, Balow G, Springer RH, Bharadwaj R, Manoharan M. Maier MA, et al. Among authors: leeds jm. Biochemistry. 2002 Jan 29;41(4):1323-7. doi: 10.1021/bi011725y. Biochemistry. 2002. PMID: 11802733

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters